Journal: medRxiv

Article Title: Immunogenicity of co-administered vaccine antigens with whole-cell or acellular pertussis vaccines in infancy: a randomised controlled trial

doi: 10.1101/2025.02.16.25321528

Figure Lengend Snippet: aP, acellular pertussis vaccine; wP, whole-cell pertussis vaccine; 13vPCV, 13-valent pneumococcal conjugate vaccine

Article Snippet: All infants were administered two IM priming doses (each 0·5 mL) of the 13vPCV CRM 197 -conjugated vaccine (Pfizer) at 6 weeks and 4 months old, and a booster dose at 12 months old (hereafter referred to as a ‘2 + 1’ schedule).

Techniques:

Journal: Revista do Instituto de Medicina Tropical de São Paulo

Article Title: Innate-immune cell distribution in pediatric HIV patients and uninfected controls

doi: 10.1590/S1678-9946202466075

Figure Lengend Snippet: Altered frequency of monocytes in children and adolescents living with HIV. Frequency of classical monocytes (CD14 + CD16 − ) (A), intermediate monocytes (CD14 + CD16 + ) (B), and non-classical monocytes (CD14 int CD16 + ) before immunization (T0), after the first MCC dose (T1), before the booster dose (T2), and after the second dose (T3). Monocyte populations are expressed as the frequency of live monocytes (MO). P-values were estimated employing the Mann-Whitney test. * p <0.05. cART = combined antiretroviral therapy, CALHIV = children and adolescents living with HIV, HU = HIV-uninfected.

Article Snippet: HU and CALHIV groups received one or two doses of the MCC vaccine (Novartis; C polysaccharide/CRM 197 ), respectively.

Techniques: MANN-WHITNEY